[PDF][PDF] Diagnostic whole-body scan may not be necessary for intermediate-risk patients with differentiated thyroid cancer after low-dose (30 mCi) radioactive iodide …
EJ Jeon, E Dal Jung - Endocrinology and Metabolism, 2014 - synapse.koreamed.org
Background: A diagnostic whole-body scan (WBS) is recommended 6 to 12 months after
total thyroidectomy and radioactive iodide ablation in intermediate-or high-risk patients with …
total thyroidectomy and radioactive iodide ablation in intermediate-or high-risk patients with …
The role of routine diagnostic radioiodine whole-body scintigraphy in patients with high-risk differentiated thyroid cancer
SG de Meer, MR Vriens, PM Zelissen… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Follow-up diagnostic radioiodine whole-body scintigraphy (DxWBS) is still advised for high-
risk patients with differentiated thyroid cancer. The aim of this study was to evaluate the …
risk patients with differentiated thyroid cancer. The aim of this study was to evaluate the …
Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence
PW Rosario, MS Furtado, AFCM Filho, RX Lacerda… - Thyroid, 2012 - liebertpub.com
Background: Diagnostic radioiodine whole-body scanning (DxWBS) in combination with
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …
Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the …
Objective To investigate predictors for successful ablation and disease-free status after high-
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …
Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3)
M Dietlein, J Dressler, W Eschner… - Nuklearmedizin …, 2007 - thieme-connect.com
Version 3 of the procedure guideline for 131 I whole-body scintigraphy (WBS) is the
counterpart to the procedure guideline for radioiodine therapy (version 3) and specify the …
counterpart to the procedure guideline for radioiodine therapy (version 3) and specify the …
The value of Pre-Ablative I-131 scan for clinical management in patients with differentiated thyroid carcinoma
T van der Boom, WT Zandee, CCJ Dekkers… - Frontiers in …, 2021 - frontiersin.org
Background A diagnostic I-131 (Dx) scan is used to detect a thyroid remnant or metastases
before treatment of differentiated thyroid cancer (DTC) with I-131. The aim of this study is to …
before treatment of differentiated thyroid cancer (DTC) with I-131. The aim of this study is to …
I-131 therapy for thyroglobulin positive patients without anatomical evidence of persistent disease
N Kamel, D Çorapcioğlu, M Şahin, A Gürsoy… - Journal of …, 2004 - Springer
Objective: the aim of this retrospective study was to evaluate the diagnostic relevance of I-
131 whole body scan (WBS) performed after second empirical therapeutic doses of iodine …
131 whole body scan (WBS) performed after second empirical therapeutic doses of iodine …
Diagnostic I–131 scintigraphy in patients with differentiated thyroid cancer: No additional value of higher scan dose
TTH Phan, KM van Tol, TP Links, DA Piers… - Annals of nuclear …, 2004 - Springer
Objective: After initial treatment with total thyroidectomy and radioiodine ablation, most
follow-up protocols for patients with differentiated thyroid carcinoma contain cyclic diagnostic …
follow-up protocols for patients with differentiated thyroid carcinoma contain cyclic diagnostic …
Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk …
F Berger, U Friedrich, P Knesewitsch… - European journal of …, 2011 - Springer
Purpose 131 I whole-body scan (WBS) and serum thyroglobulin (TG) are important in
detecting thyroid remnants or recurrent disease in patients with differentiated thyroid cancer …
detecting thyroid remnants or recurrent disease in patients with differentiated thyroid cancer …
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
KM Van Tol, PL Jager, EG De Vries… - European journal of …, 2003 - academic.oup.com
Background Management of patients with differentiated thyroid carcinoma with negative
diagnostic radioiodide scanning and increased serum thyroglobulin (Tg) concentrations is a …
diagnostic radioiodide scanning and increased serum thyroglobulin (Tg) concentrations is a …
相关搜索
- diagnostic radioiodine thyroid cancer
- body scan thyroid cancer
- low dose thyroid cancer
- risk for recurrence thyroid cancer
- outcome in patients thyroid cancer
- diagnostic radioiodine risk for recurrence
- procedure guideline thyroid cancer
- body scan prognostic implication
- body scan radioiodine therapy
- body scan early prediction
- body scan clinical response
- prognostic implication thyroid cancer
- early prediction thyroid cancer
- clinical response thyroid cancer
- scan dose thyroid cancer
- risk profile thyroid cancer